1. Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma
- Author
-
Hong-chuan Zhao, Ye-Chuan Xu, Ying Chen, Wei Wang, Xiaoping Geng, Li-Xin Zhu, Ming-Ya Yang, Yan Zhang, Fan Huang, Tao Meng, Zhi-Hua Zhang, and Yi-jun Zhao
- Subjects
Spontaneous rupture ,medicine.medical_specialty ,business.industry ,Internal medicine ,Hepatocellular carcinoma ,Propensity score matching ,medicine ,General Earth and Planetary Sciences ,business ,medicine.disease ,Gastroenterology ,General Environmental Science - Abstract
This study aims to find out the possible optimal therapy and assess the prognosis properly for patient with spontaneous rupture of hepatocellular carcinoma (HCC).Propensity score matching (PSM) analysis was used to study the data from 325 patients with ruptured HCC (RHCC) and 2,291 patients with non-RHCC.The incidence and hospital mortality of RHCC were 5.1% and 0.8% respectively, with a median overall survival (OS) time of 17 months. There was no difference between ruptured and non-RHCC patients undergoing conservation treatment in terms of OS. Trans-arterial embolization (TAE) was carried out in 69 (21.2%) cases with RHCC, with a median OS of 7 months, which was no difference from that of non-RHCC (pre- and post-PSM). One hundred and sixty-nine (52.0%) RHCC cases underwent one-stage hepatectomy, with a median OS and disease-free survival (DFS) of 30 and 6 months respectively, which were shorter than that of non-RHCC (post-PSM). TAE plus two-stage hepatectomy was performed in 30 RHCC cases, with a median OS and DFS of 28 and 10 months respectively; these outcomes were better than that from RHCC patients undergoing TAE alone or one-stage hepatectomy (post-PSM), which were no difference from that of non-RHCC patients undergoing hepatectomy. The risk of death for RHCC patient undergoing one-stage hepatectomy is 1.545 times higher than that of one undergoing TAE + two-stage hepatectomy.TAE plus two-stage hepatectomy might be the optimal treatment for RHCC patient. Under the premise of the same pathological properties, there is no difference in prognosis between ruptured and non-RHCC patients if the therapy is appropriate.
- Published
- 2022